EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Impact of Menstrual Cycle and Oral Contraceptives on Haematological and Inflammatory Biomarkers in Highly Trained Female Athletes

Katia Collomp iD, Caroline Teulier, Carole Castanier, Juliette Bonnigal, Alexandre Marchand, Corinne Buisson, Magnus Ericsson, Nathalie Crépin, Emmanuelle Duron, Eric Favory, Mathieu Zimmermann, Virgile Amiot und 1 weitere

Drug Testing and Analysis · 2025

DOI: 10.1002/dta.3859 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Katia Collomp und 12 weiteren Autor:innen. Beteiligte Einrichtung: CIAMS, Université d'Orléans, Orléans, France. Hauptthemen laut MEDLINE: Athletes, Menstrual Cycle, Contraceptives, Oral, Combined, Contraceptives, Oral. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: World Anti-Doping Agency, Institut Français du Cheval et de l'Equitation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Haematological and inflammatory biomarkers play an important role in athlete performance and health, with some of them used in the fight against doping. However, little is known about how they are modulated by sex hormone fluctuations in highly trained female athletes. We therefore measured the haematological parameters monitored in the athlete biological passport (ABP) as well as erythropoietin, serum markers of iron and inflammatory statuses (iron, ferritin, transferrin, transferrin saturation, albumin, creatinine, total protein, interleukin‐6 and TNF‐alpha) in 20 highly trained female athletes: 10 with normal menstrual cycle (NMC) during the early follicular and mid‐luteal phases and 10 using a combined oral contraceptive (COC, i.e., ethinyloestradiol and levonorgestrel) during active and inactive hormone intake. Body composition, leptin and lipid profile (total cholesterol, HDL, LDL and triglycerides) were determined in parallel. No changes were observed throughout NMC phases. Irrespective of active/inactive pill intake, COC use increased transferrin, triglycerides as well as reticulocyte count ( p < 0.05) and decreased interleukin‐6 ( p < 0.05), with no significant changes in the other parameters studied. In conclusion, given our results across NMC phases in highly trained athletes, it seems warranted to investigate whether intense physical training would mitigate the impact of endogenous sex hormones on body composition and haematological and inflammatory parameters. In addition, further studies are needed to determine the extent of the changes induced by COCs on these blood biomarkers in elite female athletes when subjected to extreme environments such as intensive training or competition in humid heat, cold and/or hypoxia or when using other medications in parallel.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AthletesMenstrual CycleContraceptives, Oral, CombinedContraceptives, OralHumansFemaleBiomarkersAdultYoung AdultDoping in SportsInflammationErythropoietinLevonorgestrelEthinyl EstradiolLipidsBody CompositionIron

Stichwörter der Autor:innen

contraceptionelite female athleteshormonal statusreticulocytestransferrin

Substanzen

BiomarkersContraceptives, Oral, CombinedErythropoietinLevonorgestrelEthinyl EstradiolContraceptives, OralLipidsIron

Autor:innen und Institutionen

  • CIAMS, Université d'Orléans, Orléans, France.
  • CIAMS, Université Paris-Saclay, Saclay, France.
  • SAPREM, Université d'Orléans, Orléans, France.
  • LADF, Université Paris-Saclay, Saclay, France.
  • IFCE, Cadre Noir, Saumur, France.
  • Hôpital Brousse, AP-HP, Villejuif, Equipe INSERM MOODS-CESP, Kremlin-Bicêtre, France.

ORCID-Profile: Katia Collomp

Förderung

  • World Anti-Doping Agency
  • Institut Français du Cheval et de l'Equitation

Zitieren

APA

Collomp, K., Teulier, C., Castanier, C., Bonnigal, J., Marchand, A., Buisson, C., Ericsson, M., Crépin, N., Duron, E., Favory, E., Zimmermann, M., Amiot, V., & Olivier, A. (2025). Impact of Menstrual Cycle and Oral Contraceptives on Haematological and Inflammatory Biomarkers in Highly Trained Female Athletes. Drug Testing and Analysis. https://doi.org/10.1002/dta.3859

Vancouver

Collomp K, Teulier C, Castanier C, Bonnigal J, Marchand A, Buisson C, et al. Impact of Menstrual Cycle and Oral Contraceptives on Haematological and Inflammatory Biomarkers in Highly Trained Female Athletes. Drug Testing and Analysis. 2025. doi:10.1002/dta.3859

BibTeX
@article{Collomp2025,
  author = {Collomp, Katia and Teulier, Caroline and Castanier, Carole and Bonnigal, Juliette and Marchand, Alexandre and Buisson, Corinne and Ericsson, Magnus and Crépin, Nathalie and Duron, Emmanuelle and Favory, Eric and Zimmermann, Mathieu and Amiot, Virgile and Olivier, Agnès},
  title = {Impact of Menstrual Cycle and Oral Contraceptives on Haematological and Inflammatory Biomarkers in Highly Trained Female Athletes},
  journal = {Drug Testing and Analysis},
  year = {2025},
  doi = {10.1002/dta.3859}
}
Kostenlos starten →